Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Which antirheumatic drug?

F D Hart

    Drugs
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Effective rheumatic disease treatment requires precise drug selection for individual patients and conditions. This includes tailored therapies for gout, rheumatoid arthritis, and systemic lupus erythematosus, emphasizing timely and appropriate interventions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Posturing in Bronchography.

    British medical journal·2010
    Same author

    Glandular Fever with Neutropenia.

    British medical journal·2010
    Same author

    Oral Thyroxine in the Treatment of Myxoedema.

    British medical journal·2010
    Same author

    Indomethacin suppositories for arthritis.

    British medical journal·2010
    Same author

    Ankylosing spondylitis and fluorosis.

    Lancet (London, England)·2010
    Same author

    Febrile Anæmia of Obscure Origin.

    Proceedings of the Royal Society of Medicine·2009
    Same journal

    Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

    Drugs·2026
    Same journal

    Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

    Drugs·2026
    Same journal

    Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

    Drugs·2026
    Same journal

    Relacorilant: First Approval.

    Drugs·2026
    Same journal

    Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

    Drugs·2026
    Same journal

    Linerixibat: First Approval.

    Drugs·2026
    See all related articles

    Area of Science:

    • Rheumatology
    • Pharmacology
    • Internal Medicine

    Background:

    • Chronic rheumatic diseases necessitate individualized treatment strategies.
    • Gout, rheumatoid arthritis, and systemic lupus erythematosus present unique therapeutic challenges.
    • Optimal drug selection is crucial for successful patient outcomes.

    Purpose of the Study:

    • To evaluate current therapeutic approaches for common rheumatic diseases.
    • To discuss the appropriate use of various drug classes in rheumatology.
    • To highlight the importance of timing and patient-specific factors in treatment success.

    Main Methods:

    • Review of established treatment protocols for gout, rheumatoid arthritis, and systemic lupus erythematosus.
    • Analysis of drug efficacy, toxicity, and long-term management strategies.

    Related Experiment Videos

  • Evaluation of the role of corticosteroids and immunosuppressive agents.

    • Main Results:

    • Gout treatment requires distinct approaches for acute episodes versus long-term management.
    • Rheumatoid arthritis treatment is often empirical, progressing from milder to more potent agents.
    • Corticosteroids remain primary for systemic lupus erythematosus, with cytotoxic agents playing a secondary role.

    Conclusions:

    • Successful rheumatic disease management hinges on precise drug selection, patient-specific needs, and timely intervention.
    • Misapplication of therapies, such as using long-term gout suppressors for acute attacks, can be detrimental.
    • A nuanced approach, considering disease severity and patient response, is essential across rheumatologic conditions.